ALDH1A1 and cervical cancer: We showed that the SiRNA-transfected HeLa cells had lower migration rates than the control (Fig. 5a, c), whereas the HeLa-ALDH1-positive cells had significantly higher migration rates than their control cells (Fig. 5b, d), suggesting that ALDH1 is an effective target for treating cervical cancer metastases.